Saudi Arabia is transforming its healthcare landscape under Vision 2030, with a strong focus on localizing pharmaceutical production and reducing dependence on imports. One of the most impactful developments is the rise of contract manufacturing oncology drugs. This model allows global innovators and local manufacturers to collaborate, bringing advanced cancer therapies closer to patients faster,